Annovis Bio stockholders elect all five director nominees and ratify Ernst & Young as auditor

Annovis Bio, Inc.

11,588,981 shares (59.47% of outstanding) represented at June 17, 2025 annual meeting.
Directors Maccecchini, Hoffman, Bruck, McCarthy, White elected; broker non-votes ~7.2M each.
Ratification of Ernst & Young LLP as independent auditor passed with 11,382,542 votes for.
Auditor ratification had 187,959 against and 18,480 abstain; no other proposals voted.

item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.